Contineum Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	20.16	75.6	21.94	15.53	5.57	4.63
Short-Term Investments	226.17	187.29	182.82	109.66	41.67	64.37
Cash & Short-Term Investments	246.33	262.9	204.76	125.19	47.24	69
Cash Growth	29.16%	28.39%	63.56%	165.01%	-31.54%	-
Other Current Assets	6.64	5.02	1.63	2.52	1.15	0.78
Total Current Assets	252.96	267.92	206.39	127.71	48.39	69.78
Net Property, Plant & Equipment	8.07	8.47	6.46	1.4	2.12	0.64
Other Long-Term Assets	0.31	0.26	0	1.28	0.13	0.1
Total Assets	261.35	276.64	212.85	130.39	50.64	70.52
Accounts Payable	1.5	1.02	1.81	0.64	0.43	0.66
Accrued Expenses	2.86	6.39	6.71	4.39	2.06	1.76
Current Portion of Long-Term Debt	-	-	-	-	3.95	1.25
Current Portion of Leases	2.3	2.34	1.45	0.46	1.11	-
Total Current Liabilities	6.66	9.74	9.97	5.48	7.55	3.67
Long-Term Debt	-	-	-	-	-	3.66
Long-Term Leases	4.65	5.91	4.81	0.11	0.79	-
Other Long-Term Liabilities	-	-	-	0.11	3.03	1.6
Total Long-Term Liabilities	4.65	5.91	4.81	0.22	3.82	5.26
Total Liabilities	11.31	15.65	14.78	5.7	11.37	8.93
Common Stock	0.04	0.04	0.03	0	0	0.01
Additional Paid-in Capital	442.09	438.07	315.37	7.1	4.73	2.74
Accumulated Other Comprehensive Income	-0.25	0.26	0.07	0.11	-0.08	-0.04
Retained Earnings	-191.84	-177.38	-117.4	-75.14	-97.86	-73.61
Total Common Shareholders' Equity	250.04	260.99	198.07	-67.94	-93.21	-70.89
Minority Interest	-	-	-	192.62	132.48	132.48
Shareholders' Equity	250.04	260.99	198.07	124.68	39.27	61.59
Total Liabilities & Equity	261.35	276.64	212.85	130.39	50.64	70.52
Total Debt	6.95	8.25	6.26	0.57	5.85	4.91
Net Cash (Debt)	239.37	254.65	198.5	124.62	41.39	64.1
Net Cash Growth	-6.00%	28.28%	59.29%	201.08%	-35.42%	-
Net Cash Per Share	7.83	9.19	10.26	36.70	18.45	30.43
Book Value	250.04	260.99	198.07	-67.94	-93.21	-70.89
Book Value Per Share	8.18	9.42	10.23	-20.01	-41.56	-33.66
Tangible Book Value	250.04	260.99	198.07	-67.94	-93.21	-70.89
Tangible Book Value Per Share	8.18	9.42	10.23	-20.01	-41.56	-33.66

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q